{
  "id": 18344755,
  "title": "WHO Greenlights Two Ebola Bundibugyo Virus Vaccine Candidates for Phase 2/3 Trials",
  "url": "https://urgent.news/2026/11/05/who-greenlights-two-ebola-bundibugyo-virus-vaccine-candidates-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T17:30:28.000Z",
  "source": {
    "name": "Health Policy Watch",
    "slug": "health-policy-watch",
    "url": "https://healthpolicy-watch.news/who-greenlights-two-ebola-bundibugyo-virus-vaccine-candidates-for-phase-2-3-trials/"
  },
  "original_language": "en",
  "account": null,
  "summary": "WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence “within three to four weeks” – as soon as DRC regulators issue their own approval, said WHO’s Science Director Meg Doherty, at a Wednesday […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}